---
tags: Tuesday
---

# 2024-10-08

Attending: Will, Josh, Petr, Dom, Kyle, Tom, Khaled, Seb, Frances, Chris, David S, Melissa, 

Start: 2:00 pm UK

## Accepting minutes from [last meeting](https://hackmd.io/team/ome?nav=overview)

## Project Status

(2-3 minutes each)

- IDR Frances: idr0158 released today. Multiplexed immuno study. 40 antibodies. New mapr config for antibodies.
- Meeting on IDR search on Thursday morning. e.g migrate away from mapr. Small steps starting ASAP.
- NGFF challenge. Samples viewer (work in progress) to show converted zarr v3 data.

- OMERO

- Bio-Formats: Melissa: on track for BF 8.0.0 release week of 21st.

- NGFF
  - Josh: Challenge:
    - https://ome.github.io/ome2024-ngff-challenge/ now live
    - Few sites dribbling in (Crick, Jülich, Göttingen)
  - RFCs
    - https://ngff.openmicroscopy.org/rfc/5 published
    - RFC-3 still needs work
    - Reviewers to contact

- GerBI:
  - Tom: OMERO IT Workshop in Heidelberg next week. 22 participants from 11 institutions: core facility + IT together. :handshake: 
    - Petr: How? What will you concretely set up and how ?
    - Tom: first day discuss & get them to interact with each other, same language. second day is more practical on VMs (provided by IT themselves) to run ansible playbooks, explain /Files, etc.
  - [FAIRDOM](https://fairdomhub.org/) presentation last week at AIMM/BINA. YouTube link to come...
  - BioMedical meeting in Heidelberg (Nov): https://indico.dkfz.de/e/nfdi-biomed ("metadata")
  - Spatial data meeting in Berlin (Dec): https://indico.dkfz.de/event/1112/
  - Continued work on [OMERO-vitessce integration](https://github.com/NFDI4BIOIMAGE/omero-vitessce?tab=readme-ov-file#development)
  - Registry of OMEROs?

- Glencoe: Chris:
    - Elrig Drug discovery London [Meeting last week](https://elrig.org/portfolio/drug-discovery-2024/) (David)
        - SPI2 were running one of the 4 tracks. Not a lot of imaging in general but presentation well received. 

- Community
    - Japan: workshops 4th & 6th November.

## AOB

(5 min. max; tech. Discussion should be highlighted to relevant people and rescheduled)

## Main Topic

(20-25 minutes plus 15 minutes questions max)
